Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Purpose

A prospective, non-interventional, natural history study to assess the occurrence of higher FNAIT risk across a broad population of different racial and ethnic characteristics and the occurrence of HPA-1a alloimmunization in these women.

Condition

  • Fetal and Neonatal Alloimmune Thrombocytopenia

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Pregnant women (≥ 18 years of age) who have provided informed consent for the study.

Exclusion Criteria

  • Participants with prior history of FNAIT

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Pregnant women Women with higher risk of FNAIT
  • Other: Clinical data collection
    Laboratory tests, Vital assessments, Maternal and fetal genotype testing, Antibodies Testing will be performed.

More Details

Status
Completed
Sponsor
Rallybio

Study Contact